Palatin Technologies Files S-1 Registration Statement

TL;DR

<b>Palatin Technologies has filed an S-1 registration statement, signaling potential future public offerings.</b>

AI Summary

PALATIN TECHNOLOGIES INC (PTN) filed a IPO Registration (S-1) with the SEC on March 14, 2024. Palatin Technologies, Inc. filed an S-1 registration statement with the SEC on March 14, 2024. The filing indicates Palatin Technologies is a smaller reporting company and a non-accelerated filer. The company's principal executive offices are located at 4B Cedar Brook Drive, Cranbury, New Jersey 08512. The fiscal year end for Palatin Technologies is June 30. The filing is for a registration statement under the Securities Act of 1933.

Why It Matters

For investors and stakeholders tracking PALATIN TECHNOLOGIES INC, this filing contains several important signals. This S-1 filing is a prerequisite for Palatin Technologies to offer securities to the public, potentially raising capital for its operations or expansion. As a smaller reporting company and non-accelerated filer, Palatin Technologies may have different disclosure requirements and regulatory scrutiny compared to larger entities.

Risk Assessment

Risk Level: low — PALATIN TECHNOLOGIES INC shows low risk based on this filing. The filing is a standard S-1 registration statement, which is a preliminary step for public offerings and does not inherently indicate immediate financial distress or significant new risks.

Analyst Insight

Monitor future filings for details on any proposed securities offerings, including the number of shares, pricing, and intended use of proceeds.

Key Numbers

• 20240314 — Filing Date (Date of S-1 filing)
• 0630 — Fiscal Year End (Palatin Technologies' fiscal year end)
• 333-277934 — SEC File Number (SEC file number for the registration statement)
• 95-4078884 — IRS Number (IRS Employer Identification No.)

Key Players & Entities

• Palatin Technologies, Inc. (company) — Registrant name
• Stephen T. Wills (person) — Executive Vice President, Chief Financial Officer and Chief Operating Officer
• Faith L. Charles, Esq. (person) — Copies to counsel
• Thompson Hine LLP (company) — Counsel for registrant
• Stephen A. Slusher, Esq. (person) — Chief Legal Officer
• Delaware (jurisdiction) — State of incorporation
• NJ (state) — State of incorporation
• 08512 (zip_code) — Business address zip code

FAQ

Industry Context

Palatin Technologies operates in the pharmaceutical preparations industry, focusing on the development of novel therapeutics.

Regulatory Implications

The S-1 filing is made under the Securities Act of 1933, which governs the registration of securities offered to the public.

What Investors Should Do

1. Review the full S-1 filing for detailed information on the company's business, financials, and risk factors.
2. Track subsequent SEC filings for any updates regarding proposed securities offerings.
3. Analyze the company's financial health and strategic plans once more detailed information becomes available.

Key Dates

• 2024-03-14: S-1 Filing — Registration statement filed with the SEC.

Year-Over-Year Comparison

This is an S-1 filing, which is a registration statement for potential future offerings. No prior filing of this type is indicated in the provided text.

Key Financial Figures

• $0.01 — 3,078 shares of common stock, par value $0.01 per share, of Palatin Technologies, Inc
• $1.71 — r common stock on the NYSE American was $1.71 per share. This prospectus describes
• $100.0 million — ecause our annual revenue was less than $100.0 million during the most recently completed fisc
• $560.0 million — ck held by non-affiliates was less than $560.0 million on the last business day of our most re
• $5.46 — stock at a per share purchase price of $5.46. In a concurrent private placement ("Pr
• $9.2 million — received net proceeds of approximately $9.2 million from the February Financing, after dedu
• $6.825 — gent Warrants have an exercise price of $6.825 per share. We refer to the Private Wa
• $2 million — company to have stockholders' equity of $2 million or more if the listed company has repor
• $4 million — company to have stockholders' equity of $4 million or more if the listed company has repor

Filing Documents

• ptn_s1.htm (S-1) — 296KB
• ptn_ex51.htm (EX-5.1) — 13KB
• ptn_ex232.htm (EX-23.2) — 2KB
• ptn_ex107.htm (EX-FILING FEES) — 11KB
• ptn_s1img9.jpg (GRAPHIC) — 88KB
• ptn_s1img4.jpg (GRAPHIC) — 8KB
• ptn_s1img3.jpg (GRAPHIC) — 8KB
• ptn_ex51img4.jpg (GRAPHIC) — 1KB
• ptn_ex51img3.jpg (GRAPHIC) — 9KB
• ptn_ex51img2.jpg (GRAPHIC) — 5KB
• ptn_ex51img1.jpg (GRAPHIC) — 9KB
• 0001654954-24-003174.txt (&nbsp;) — 499KB

USE OF PROCEEDS

USE OF PROCEEDS 6 DIVIDEND POLICY 6

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 7 SELLING STOCKHOLDERS 9 PLAN OF DISTRIBUTION 12 LEGAL MATTERS 14 EXPERTS 14 WHERE YOU CAN FIND MORE INFORMATION 14 INFORMATION WE INCORPORATE BY REFERENCE 14 No dealer, salesperson, or other person is authorized to give any information or to represent anything not contained in this prospectus. You must not rely on any unauthorized information or representations. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date. ii Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This prospectus, including the documents incorporated by reference, contains, and any prospectus supplement may contain, "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include, but are not limited to, statements about: our significant operating losses since our inception and our need to obtain additional financing has caused management to determine there is substantial doubt regarding our ability to continue as a going concern; our ability to obtain additional financing on terms acceptable to us, or at all, including unavailability of funds or delays in receiving funds as a result of economic disruptions; our expectation that we will incur losses for the foreseeable future and may never achieve or maintain profitability; our business, financial condition, and results of operations may be adversely

RISK FACTORS

RISK FACTORS Investing in our common stock involves risk. Prior to making a decision about investing in our common stock, you should carefully consider the risk factors below as well as those discussed under the heading "Risk Factors" in our most recent annual report on Form 10-K, which is incorporated herein by reference and may be amended, supplemented, or superseded from time to time by other reports we have filed with the SEC or will file with the SEC in the future. If any of these risks actually occurs, our business, results of operations, and financial condition could suffer. In that case, the trading price of our common stock could decline, and you could lose all or a part of your investment. Risks Related to this Offering The sale or availability for sale of shares issuable pursuant to this prospectus may depress the price of our common stock, dilute the interest of our existing stockholders, and encourage short sales by third parties, which could further depress the price of our common stock. To the extent that the Selling Stockholders sell shares of our common stock pursuant to this prospectus, the market price of our common stock may decrease due to the additional selling pressure in the market. In addition, the dilution from exercise of the Warrants may cause stockholders to sell their shares of our common stock, which could further contribute to any decline in the price of our common stock. Any downward pressure on the price of our common stock caused

View Full Filing

View this S-1 filing on SEC EDGAR